VENETOCLAX
DrugBank ID: db11581
DrugCentral: venetoclax
Synonymous :4-{4-[(4’-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1’-biphenyl]]-2-yl)methyl]piperazin-1-yl}-n-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1h-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide | venetoclax
Drug Sentece Context
Table 1. Analysis of context sentence of venetoclax gene in 3 abstracts.
pmid | sentence |
---|---|
32392559 | The biology of each leukemia and its corresponding treatment with conventional intensive chemotherapy, with or without targeted therapies (venetoclax, FLT3 inhibitors, IDH1/2 inhibitors, Bruton’s tyrosine kinase inhibitors), introduce additional layers of complexity during COVID-19 high-risk periods. |
32923230 | However, he did not respond to the therapy and was started on re-induction therapy with decitabine and venetoclax. |
33477155 | On Jan 13, 2020, an extreme compassioned treatment with venetoclax alone was started; this drug was well tolerated and provided a satisfactory clinical and laboratory improvement. […] The use of venetoclax as a single drug to treat DLBCL BCL2 patients deserves further investigation. |
33567947 | methylprednisolone was withdrawn and a rituximab-venetoclax treatment was initiated without side effects. |